Concepedia

Approval Time Optimization

Approval Time Optimization is a methodological construct within change approval processes that systematically reduces the temporal latency between submission and authorization of change requests through targeted process enhancements, resource allocation strategies, and decision-making automation.

7

Publications

313

Citations

36

Authors

17

Institutions

Publications per year

2017–2026

5

Parents

Publications

7

A DYNAMIC OLIGOPOLY STRUCTURAL MODEL FOR THE PRESCRIPTION DRUG MARKET AFTER PATENT EXPIRATION*

Andrew T. Ching · International Economic Review · 2010 · 166 citations

, , +12

The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System

Andrea Keyter, Joey Gouws, Sam Salek et al. · Therapeutic Innovation & Regulatory Science · 2018 · 39 citations · Full text

, , +15

FDA Facilitated Regulatory Pathways: Visualizing Their Characteristics, Development, and Authorization Timelines

Lawrence Liberti, Magda Bujar, Alasdair Breckenridge et al. · Frontiers in Pharmacology · 2017 · 33 citations · Full text

, , +13

A Baseline Analysis of Regulatory Review Timelines for ANVISA: 2013–2016

Prisha Patel, Daniela Marreco Cerqueira, Gustavo Mendes Lima Santos et al. · Therapeutic Innovation & Regulatory Science · 2020 · 24 citations · Full text

, , +14

Proposals of statistical consideration to evaluation of results for a specific region in multi‐regional trials – Asian perspective

Hsiao‐Hui Tsou, Shein‐Chung Chow, K. K. Gordon Lan et al. · Pharmaceutical Statistics · 2010 · 23 citations

, , +16

1–5 of 7

Authors

36

  1. NM
    Neil McAuslane

    Centre for Innovation in Regulatory Science, United Kingdom

    2 publications · 57 citations

    2

    h-index

  2. LL
    Lawrence Liberti

    Centre for Innovation in Regulatory Science, United Kingdom

    2 publications · 57 citations

    2

    h-index

  3. SL
    Sabrina Livezey

    University of Tennessee Health Science Center, United States

    1 publications · 13 citations

    1

    h-index

  4. CA
    Chao A. Hsiung

    National Health Research Institutes, Taiwan

    1 publications · 23 citations

    1

    h-index

  5. MB
    Magda Bujar

    Centre for Innovation in Regulatory Science, United Kingdom

    1 publications · 33 citations

    1

    h-index

1–5 of 36

Institutions

17

  1. Centre for Innovation in Regulatory Science

    London, United Kingdom

    3 h-index

    7 publications

    210 citations

  2. Utrecht University

    Utrecht, The Netherlands

    1 h-index

    4 publications

    132 citations

  3. University of Pennsylvania

    Philadelphia, United States

    1 h-index

    3 publications

    45 citations

  4. National Taiwan University

    Taipei, Taiwan

    1 h-index

    1 publications

    23 citations

  5. Taipei Veterans General Hospital

    Taipei, Taiwan

    1 h-index

    1 publications

    23 citations

  6. South African Medical Research Council

    Cape Town, South Africa

    1 h-index

    2 publications

    78 citations

  7. University of Tennessee Health Science Center

    Memphis, United States

    1 h-index

    1 publications

    13 citations

  8. National Health Research Institutes

    Hsinchu, Taiwan

    1 h-index

    4 publications

    92 citations

1–8 of 17

Venues

  1. Therapeutic Innovation & Regulatory Science

    TIRS · 2 publications · 63 citations

    2

    h-index

  2. International Economic Review

    1 publications · 166 citations

    1

    h-index

  3. Frontiers in Pharmacology

    1 publications · 33 citations

    1

    h-index

  4. Drugs & Aging

    1 publications · 15 citations

    1

    h-index

  5. Mental Health Clinician

    MHC · 1 publications · 13 citations

    1

    h-index

1–5